陳可玫
陳可玫博士目前為安斯泰來股份有限公司之醫學事務部部長,她畢業於台灣大學生化所並在畢業後於中央研究院完成了兩年的博士後研究,她在藥廠醫學事務部已有十年以上經驗且經驗橫跨心血管疾病, 病毒學, 以及血液和腫瘤相關疾病,在藥廠時她一開始在拜耳擔任MSL,後來加入必治妥任職醫藥顧問並升遷到疾病領域顧問而後接著輪調負責台日韓區與總部的任務,她有三年以上的跨國工作經歷並且曾是總部在計畫亞洲策略的主要窗口。
陳可玫博士目前為安斯泰來股份有限公司之醫學事務部部長,她畢業於台灣大學生化所並在畢業後於中央研究院完成了兩年的博士後研究,她在藥廠醫學事務部已有十年以上經驗且經驗橫跨心血管疾病, 病毒學, 以及血液和腫瘤相關疾病,在藥廠時她一開始在拜耳擔任MSL,後來加入必治妥任職醫藥顧問並升遷到疾病領域顧問而後接著輪調負責台日韓區與總部的任務,她有三年以上的跨國工作經歷並且曾是總部在計畫亞洲策略的主要窗口。
She obtained her PhD degree for Biochemical sciences at National Taiwan University and had 2 years post-Doc training at Academia Sinica. She has more than ten years medical affairs experience in pharmaceutical companies covering broad disease areas (cardiology, virology, hematology, and Oncology). She started as a MSL in Bayer and moved to BMS as a Medical advisor. She was then promoted to Disease Area Lead and had talent rotation for Japan-Korea-Taiwan cluster and global. She worked in above country role for more than 3 years and was Worldwide Medical contact point for Asia strategy.
具有 10 年以上醫學事務經驗和 3 年以上跨越不同治療領域的醫學教育活動和醫學溝通經驗。我致力於藉由提高團隊能力和優化醫學教育活動來促進以病患為中心。
Sam has over 15 years of diversified experiences working in the pharmaceutical industry. Since the beginning of her role as Medical Affairs at Sanofi Hong Kong more than ten years ago, Sam has accumulated experiences in managing product launch, evidence generation, data dissemination and engagement in therapeutic areas such as vaccines, consumer health, rare diseases, oncology and cardiovascular diseases.
Before moving to Sanofi Taiwan as Medical Lead managing the cardiovascular portfolio in both Hong Kong and Taiwan, Sam had worked as Chief of Staff of Asia at Sanofi Singapore, alongside the regional commercial head of Asia and other regional function leaders, through which she had gained significant hands-on experiences and knowledge in business operation and commercial strategy.
Sam also has substantial expertise and experiences in Regulatory Affairs, Quality Affairs and Pharmacovigilance, due to her work experiences prior to her role of Medical Affairs.
Annie is the affiliate Medical Director for AbbVie Taiwan since 2019, leading Medical Affairs and has a solid broad spectrum of functional competencies in pharmacovigilance, research/clinical operation in real-world evidence generation, and MSL infield excellence. With unique bilateral career paths in both medical and commercial, professional experiences had recognized via robust track records in launching revolutionary breakthrough therapy and received various awards in corporate and regional level due to her strong business acumen, passionate & visionary leadership.
Prior to AbbVie, Annie was the associate medical director at Sanofi Taiwan & Hong Kong, with vast experience for 10+ years in BMS, Bayer and Novartis in medical and commercial specializing in new product launches across Immunology, Oncology, Hematology, Ophthalmology and Neurosciences. Sheobtained PhD degree from National Taiwan University in department of biochemistry specializing in enzyme kinetics and anti-bacterial drug discovery; had continued her post-doctoral fellowship in department of pharmacology, school of Medicine at Yale University in anti-cancer pre-clinical and clinical research resulted prominent peer-reviewed publications.
負責領導醫療事務戰略並在藥物安全監視、真實世界臨床證據研究/臨床試驗和 MSL infield excellence擁有廣泛的職能能力。在醫療和商業領域獨特的雙邊職業發展,她的專業經驗在上市數個突破性治療得到了認可,其明確果斷及高度的市場敏感度,熱情而富有遠見的領導力帶領團隊在企業和亞太區獲得了各種獎項。
在加入艾伯維之前,Annie 是賽諾菲台灣和香港的副醫學處長,在BMS、拜耳和諾華在醫學和商業領域擁有 10 多年的豐富經驗。 專注於免疫學、腫瘤學、血液腫瘤學、眼科和神經科學領域的新產品上市。獲台灣大學生化所博士學位,專攻酶動力學及抗菌藥物發展;繼續在耶魯大學醫學院藥理所從事抗癌在動物及臨床試驗的博士後研究並發表數篇國際論文。
Shawn Jeng is the Medical Affairs Director of ONO Pharma Taiwan with a focus on developing a highly accountable and knowledge-driven medical team. He brings his decade of experience and leadership to his current role where he is dedicated to mentoring, inspiring and motivating field medicals how to maximize science for value in patients.
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2024 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.